HomeCompareDTCFF vs ADC

DTCFF vs ADC: Dividend Comparison 2026

DTCFF yields 500.00% · ADC yields 4.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DTCFF wins by $61399.35M in total portfolio value
10 years
DTCFF
DTCFF
● Live price
500.00%
Share price
$0.40
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$61399.52M
Annual income
$44,063,578,515.70
Full DTCFF calculator →
ADC
Agree Realty Corporation
● Live price
4.13%
Share price
$74.97
Annual div
$3.10
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$178.9K
Annual income
$80,797.29
Full ADC calculator →

Portfolio growth — DTCFF vs ADC

📍 DTCFF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDTCFFADC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DTCFF + ADC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
DTCFF pays
ADC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DTCFF
Annual income on $10K today (after 15% tax)
$42,500.00/yr
After 10yr DRIP, annual income (after tax)
$37,454,041,738.34/yr
ADC
Annual income on $10K today (after 15% tax)
$351.36/yr
After 10yr DRIP, annual income (after tax)
$68,677.70/yr
At 15% tax rate, DTCFF beats the other by $37,453,973,060.65/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DTCFF + ADC for your $10,000?

DTCFF: 50%ADC: 50%
100% ADC50/50100% DTCFF
Portfolio after 10yr
$30699.85M
Annual income
$22,031,829,656.50/yr
Blended yield
71.77%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ADC right now

DTCFF
No analyst data
Altman Z
-31.5
Piotroski
1/9
ADC
Analyst Ratings
1
Strong
22
Buy
9
Hold
Consensus: Buy
Price Target
$81.06
+8.1% upside vs current
Range: $75.00 — $84.50
Altman Z
1.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DTCFF buys
0
ADC buys
0
No recent congressional trades found for DTCFF or ADC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDTCFFADC
Forward yield500.00%4.13%
Annual dividend / share$2.00$3.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.4%
Portfolio after 10y$61399.52M$178.9K
Annual income after 10y$44,063,578,515.70$80,797.29
Total dividends collected$59892.67M$156.7K
Payment frequencyquarterlymonthly
SectorStockREIT

Year-by-year: DTCFF vs ADC ($10,000, DRIP)

YearDTCFF PortfolioDTCFF Income/yrADC PortfolioADC Income/yrGap
1← crossover$60,700$50,000.00$10,990$580.36+$49.7KDTCFF
2$348,594$283,644.86$12,301$860.26+$336.3KDTCFF
3$1,895,372$1,522,376.89$14,104$1,298.62+$1.88MDTCFF
4$9,763,990$7,735,942.00$16,691$2,008.16+$9.75MDTCFF
5$47,691,977$37,244,507.54$20,580$3,205.09+$47.67MDTCFF
6$221,049,019$170,018,603.23$26,754$5,330.02+$221.02MDTCFF
7$972,993,924$736,471,474.07$37,196$9,345.14+$972.96MDTCFF
8$4,070,762,075$3,029,658,575.98$56,244$17,523.09+$4070.71MDTCFF
9$16,201,818,371$11,846,102,950.68$94,286$35,736.21+$16201.72MDTCFF
10$61,399,524,173$44,063,578,515.70$178,949$80,797.29+$61399.35MDTCFF

DTCFF vs ADC: Complete Analysis 2026

DTCFFStock

Defence Therapeutics Inc., a biotechnology company, engages in the research and development of biological/biosimilar therapeutic drugs for cancer and infectious diseases. Its proprietary platform is the ACCUMTM technology, which enables precision delivery of vaccine antigens or ADCs in their intact form to target cells. The company focuses on developing dendritic cell cancer vaccines; protein-based vaccine formulation against COVID and infectious diseases; and antibody drug conjugates (ADC) products targeting various cancers. The company was formerly known as Accum Therapeutics Inc. and changed its name to Defence Therapeutics Inc. in March 2020. Defence Therapeutics Inc. was incorporated in 2017 and is headquartered in Vancouver, Canada.

Full DTCFF Calculator →

ADCREIT

Agree Realty Corporation is a publicly traded real estate investment trust primarily engaged in the acquisition and development of properties net leased to industry-leading retail tenants. As of September 30, 2020, the Company owned and operated a portfolio of 1,027 properties, located in 45 states and containing approximately 21.0 million square feet of gross leasable area. The Company's common stock is listed on the New York Stock Exchange under the symbol ADC.

Full ADC Calculator →
📬

Get this DTCFF vs ADC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DTCFF vs SCHDDTCFF vs JEPIDTCFF vs ODTCFF vs KODTCFF vs MAINDTCFF vs NNNDTCFF vs EPRTDTCFF vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.